Cardiovasc Res 36:276281 Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M et al (2002) Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2
JqL, QL, QZ, and JnL wrote the manuscript
"Thyroid Dysfunction and Bipolar Disorder: A Literature Review Integrating Neurochemical, Endocrine, and Genetic Perspectives"
Doctor consultations Asynchronous provider consultations are included in the monthly cost
Industry impact: Suggested winners and losers The following table summarizes our predictions of the future impact of GLP-1 on various industries